Image Credit: Canva
A condition, known commonly as "black urine disease" or Alkaptonuria is a rare genetic disorder involving protein metabolism, and it has its root in the mutation of the homogentisate 1,2-dioxygenase gene, which in turn causes homogentisic acid accumulation in the body. The appearance of dark urine after exposure to air is due to this kind of accumulation; however, a variety of symptoms can be expected, such as joint stiffness, changes in pigmentation, and other long-term health complications. Although the prevalence has been estimated to be between 1 in 250,000 and 1 in 1 million people in the United States, its effects are indeed high on those affected.
Alkaptonuria is an autosomal recessive disease, meaning that the child must inherit a defective copy of the HGD gene from both parents. If both parents are carriers, their offspring have a 25% chance of inheriting two faulty genes and developing alkaptonuria. The condition is genetic but is often not diagnosed for years because it progresses slowly and its early symptoms appear to be harmless.
The most characteristic and common initial symptom of alkaptonuria is dark urine. The reason for this is due to the fact that excess HGA is excreted in the urine and upon oxidation in the presence of air, it gives the urine a brown or black color. Though it is often considered cosmetic, the long-term accumulation of HGA within the connective tissues produces more complicated health problems.
Progressive joint pain and stiffness: The accumulation of HGA in cartilage leads to early-onset osteoarthritis, making movement increasingly difficult over time.
Skin and eye pigmentation changes: Affected individuals may develop bluish or grayish discoloration of the sclera (white part of the eye) and the skin, particularly in areas exposed to friction.
Cardiovascular and respiratory problems: With age, HGA accumulation can lead to valve calcifications in the heart and stiffening of connective tissues in the respiratory tract, which can cause problems in middle and old age.
Decreased mobility and spinal problems: The spine may become stiff and painful due to chronic cartilage degeneration.
These symptoms usually begin to manifest during adulthood, leading to severe complications in a person's 40s or 50s and significantly affecting the quality of their life.
Because of its rarity, alkaptonuria is often mistaken or overlooked early in life. However, there are several ways to confirm the condition:
Urine Testing: The gold standard in the diagnosis is the testing of urine samples for high levels of homogentisic acid via gas chromatography. In case of oxidation, which changes the color of urine to black, it is indicative of alkaptonuria.
Genetic Testing: Confirmatory genetic testing reveals mutations of the HGD gene to diagnose the condition conclusively.
Blood Tests: High levels of HGA in the blood can be used as further evidence.
Imaging Studies: X-rays and MRIs will expose cartilage and joint damage characteristic of alkaptonuria.
At present, there is no cure for alkaptonuria; however, various treatment approaches can reduce its symptoms and slow the disease's progress:
Nitisinone Therapy: Nitisinone is a drug that inhibits the production of HGA. It has been shown to reduce HGA levels and slow tissue damage. However, it needs to be taken under close medical supervision because of potential side effects.
Low-Protein Diet: Since HGA is a byproduct of protein metabolism, reducing protein intake—especially foods rich in tyrosine and phenylalanine—may help decrease HGA production.
Pain Management: OTC pain relievers and anti-inflammatory medications can be used to relieve joint pain and stiffness.
Physical Therapy: Exercise regularly, as it may improve mobility and strengthen muscles, thus reducing strain on affected joints.
Surgical Interventions: Most people with alkaptonuria develop severe osteoarthritis necessitating joint replacement in their old age. Also, some may require heart valve replacement surgery if cardiovascular complications develop.
Although alkaptonuria is not fatal, it severely affects the quality of life. The progressive deterioration of the joints and associated symptoms can make everyday activities difficult, requiring lifestyle changes and medical interventions. The disease may cause premature aging of the joints, requiring walking aids and mobility assistance earlier than expected.
Ongoing research will continue to work on improving the treatment options by focusing on gene therapy and alternative enzyme replacement therapies. However, because of its rarity, the clinical trials and research remain sparse.
As genetic research advances, more hope for better management and possible curative approaches for alkaptonuria exists. Scientists are searching extensively for enzyme replacement therapies and innovative drugs that can target the root cause of the disorder. Being aware and being diagnosed early helps individuals better their condition and ultimately have better long-term health outcomes.
Alkaptonuria is a striking example of how one gene mutation can have widespread effects on the body. Though still a rare and often misunderstood condition, growing awareness and advances in treatment are paving the way for better care. If you or a loved one suspect symptoms of alkaptonuria, it is essential to seek early diagnosis and medical guidance to manage the disease effectively and preserve quality of life.
Credit: AI Image
Amid the ongoing monsoon season, Delhi-NCR is seeing a rise in H1N1 influenza cases, with Delhi reporting 1,344 cases so far this season.
The figure is nearly six times higher than the 229 H1N1 cases recorded during the same period last year, The Times of India reported.
According to health officials, Delhi recorded around 4,000 influenza cases last year, most of them caused by H3N2. This year, H1N1 is the dominant strain. Both H1N1 and H3N2 are subtypes of Influenza A and spread mainly through respiratory droplets.
H1N1 is a subtype of Influenza A and can cause sudden fever, cough, sore throat, headache, body aches and fatigue. These symptoms can overlap with those of other seasonal influenza strains, COVID-19 and respiratory syncytial virus (RSV), making it difficult to identify the infection based on symptoms alone.
Dr Aijaz Ilmi, Senior Consultant – Metabolic Diseases, Pacific OneHealth Hospital, told HealthandMe that testing is particularly important when fever or respiratory symptoms persist or worsen, especially among older adults, young children, pregnant women and people with diabetes, obesity, heart or lung disease, or compromised immunity.
“With the current rise in H1N1 cases in Delhi, we are also seeing other seasonal respiratory infections, including Influenza A and B, COVID-19, RSV and other respiratory viruses. At the same time, the monsoon season brings an increased risk of mosquito-borne illnesses such as dengue.
“The key message is, don’t panic, but don’t dismiss a persistent fever as ‘just a viral’. Early recognition is particularly important in vulnerable individuals.”
H1N1 can be difficult to distinguish from other respiratory infections because many of them cause similar symptoms.
Dr Sharwari Sudhir Dabhade, Consultant - Internal Medicine, Diabetology & Endocrinology, Madhukar Rainbow Children's Hospital, told HealthandMe that prevention should focus on reducing exposure and maintaining good hygiene. Other measures to reduce transmission include:
Most viral respiratory infections recover with supportive care. However, should seek prompt immediate medical assessment in cases of
Credit: AI
People with inflammatory bowel disease (IBD) may face a higher risk of depression, anxiety and other psychiatric disorders years before they are diagnosed with the gut condition, a new study has discovered.
The study, published in Clinical Gastroenterology and Hepatology, found that the risk of psychiatric disorders began rising two to three years before an IBD diagnosis, peaked shortly after diagnosis and remained elevated for as long as a decade.
Researchers from Karolinska Institutet and other Swedish institutions analysed data from 43,862 people with IBD, comparing them with nearly 179,000 individuals from the general population and more than 26,000 IBD-free full siblings.
The sibling comparison was key as it helped researchers examine whether shared genetic or early-life environmental factors could explain any association.
Also read: Monsoon Gut Health: Addressing The Rise In Rotavirus And Viral Gastroenteritis Cases
The study found that the risk of developing any mental health disorder was already 15% higher two years before IBD diagnosis. It increased further around the time of diagnosis, reaching a roughly 50% higher risk within the first six months.
Although the risk reduced afterwards, it remained about 19% higher even 10 years after diagnosis. Major depressive disorder, anxiety disorders and substance misuse accounted for much of the increase.
Antidepressant and anti-anxiety medication use also began rising around a year before the IBD diagnosis.
Researchers called for mental health screening to begin early, including during the initial gastroenterology evaluation.
“It is time to actively manage psychiatric conditions in patients with IBD,” said Jiangwei Sun, PhD, the study’s lead author.
Also read: Following A Western Diet? Changes In Your Gut Bacteria Could Increase Colon Cancer Risk
IBD includes Crohn’s disease and ulcerative colitis, autoimmune conditions that cause inflammation in the digestive tract.
One possible explanation is the gut-brain axis, the two-way communication system connecting the digestive system and brain.
Inflammation, changes in gut bacteria and abnormal immune activity may affect brain function and overall mood. At the same time, stress and psychological distress can affect the gastrointestinal symptoms.
But researchers caution that the study merely shows an association, not proof that IBD directly causes depression or anxiety.
Some people may experience subtle or unexplained gastrointestinal symptoms before receiving an official diagnosis, while the uncertainty and disruption caused by chronic symptoms could also affect mental health.
The findings follow previous research that shows psychiatric symptoms can surface before the patient is diagnosed with IBD.
A 2023 study examining longitudinal health records found that anxiety and depression occurred more frequently among people who were later diagnosed with IBD.
In a 2024 systematic review and meta-analysis, it was observed that patients with a history of depression may have a small-to-moderate increased risk of subsequently developing IBD, suggesting that the relationship between the gut and mental health could work in both directions.
The new findings therefore signal that mental health symptoms may sometimes arrive years before IBD itself is formally diagnosed in patients.
For doctors, researchers say this highlights the need to treat IBD as more than a digestive disease, with psychological support and screening considered part of long-term care.
Credit: AI
Many people may dismiss swelling in an arm or leg, particularly if it's not painful. But if the swelling continues or keeps coming back, it could be a sign of lymphedema, a condition that affects the body's lymphatic system.
The lymphatic system is responsible for draining excess fluid from body tissues. If this system is damaged or is not functioning correctly, fluid will accumulate, and lead to swelling. There are different causes of lymphedema such as some infections, injuries, congenital disorders and cancer therapies. Women who have had breast or gynaecological cancers may be at special risk if they had their lymph nodes removed or if radiation had been used.
Sometimes, lymphedema develops gradually. Signs and symptoms include swelling of one arm or leg, heaviness or tightness in the arm or leg, trouble putting on rings or a watch, and decreased movement in the arm or leg.
At times, the skin can also be tight and turn into a hard consistency over time. In certain patients, a second infection of the skin may occur.
These symptoms should not just be attributed to "normal swelling. An early evaluation may help determine the root cause and make the condition less complicated to deal with.
Also read: Full-Fat Dairy May Actually Be Healthy, Not Harm Weight or Cholesterol, Study Finds
Treatment will depend on the severity of the disease and its etiology. Treatment usually involves compression garments, special physiotherapy, gentle lymphatic massage, exercises and skin care. The techniques may be used to help decrease swelling and movement.
Surgery may be necessary in some cases of more severe or chronic lymphedema. New pathways can be created to allow the excess fluid to pass, such as in a lymphovenous bypass. For some patients, a transfer of lymph nodes or liposuction may be an option.
Additionally, for patients who have an increased risk of developing lymphedema, doctors may also recommend preventive measures for individuals who must have some type of cancer surgery. This implies that measures should be taken to ensure protection of the lymphatic drainage before any appreciable swelling occurs.
Also read: NIH Chief Urges Parents To Vaccinate Children As Measles Outbreak Breaks 35 Year Record
If swelling isn't severe, don't wait to get help. If there is any continued or unexplained swelling, there will be a specialist available to give information about the cause of the swelling and what treatment is appropriate.
Patients are provided with a holistic treatment pathway for lymphedema with multiple specialists treating their patients who came together for the diagnosis, rehabilitation and surgical treatment of lymphedema.
Treatment of lymphedema is not all about reducing swelling. The overall aim is to maintain a person's function, ease and independence in their daily activities.
If diagnosed early, and appropriately treated and followed-up, lymphedema can be managed successfully and patients can lead their life with a growing sense of confidence and comfort.
© 2024 Bennett, Coleman & Company Limited